» Articles » PMID: 27431387

In Vitro Effects of 0 to 120 Grays of Irradiation on Bone Viability and Release of Growth Factors

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2016 Jul 20
PMID 27431387
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: High dose radiation therapy is commonly used in maxillofacial surgeries to treat a number of head and neck tumors. Despite its widespread use, little information is available regarding the effects of irradiation on bone cell viability and release of growth factors following dose-dependent irradiation.

Methods: Bone samples were collected from porcine mandibular cortical bone and irradiated at doses of 0, 7.5, 15, 30, 60 and 120 Grays. Thereafter, cell viability was quantified, and the release of growth factors including TGFβ1, BMP2, VEGF, IL1β and RANKL were investigated over time.

Results: It was observed that at only 7.5Gy of irradiation, over 85 % of cells were non-vital and by 60 Gy, all cells underwent apoptosis. Furthermore, over a 7-fold decrease in VEGF and a 2-fold decrease in TGFβ1 were observed following irradiation at all tested doses. Little change was observed for BMP2 and IL1β whereas RANKL was significantly increased for all irradiated samples.

Conclusions: These results demonstrate the pronounced effects of irradiation on bone-cell vitality and subsequent release of growth factors. Interestingly, the largest observed change in gene expression was the 7-fold decrease in VEGF protein following irradiation. Future research aimed at improving our understanding of bone following irradiation is necessary to further improve future clinical treatments.

Citing Articles

Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.

Tomioka A, Shimizu T, Kagota S, Taniguchi K, Komeda K, Asakuma M Ann Surg Oncol. 2020; 28(7):3789-3797.

PMID: 33244738 DOI: 10.1245/s10434-020-09401-w.


Development of an experimental model for radiation-induced inhibition of cranial bone regeneration.

Jung H, Lee J, Lee S, Lee J, Kwon T, Kwon T Maxillofac Plast Reconstr Surg. 2018; 40(1):34.

PMID: 30525010 PMC: 6249347. DOI: 10.1186/s40902-018-0173-1.

References
1.
Jereczek-Fossa B, Orecchia R . Radiotherapy-induced mandibular bone complications. Cancer Treat Rev. 2002; 28(1):65-74. DOI: 10.1053/ctrv.2002.0254. View

2.
Marx R . A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983; 41(6):351-7. DOI: 10.1016/s0278-2391(83)80005-6. View

3.
Curi M, Dib L . Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg. 1997; 55(6):540-4; discussion 545-6. DOI: 10.1016/s0278-2391(97)90478-x. View

4.
Ma Y, Xu W, Yin H, Huang Q, Liu T, Yang X . Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review. Eur Spine J. 2015; 24(8):1754-60. DOI: 10.1007/s00586-015-3834-0. View

5.
Jacobsson M, Kalebo P, Tjellstrom A, Turesson I . Bone cell viability after irradiation. An enzyme histochemical study. Acta Oncol. 1987; 26(6):463-5. DOI: 10.3109/02841868709113719. View